Kodiak Sciences (KOD) Cash from Investing Activities (2017 - 2026)
Kodiak Sciences (KOD) reported Cash from Investing Activities of -$942000.0 for Q1 2026, down 248.89% on a YoY basis from $632686.6 in Q1 2025, and down 2090.7% quarter-over-quarter from -$43000.0 in Q4 2025.
Kodiak Sciences (KOD) Cash from Investing Activities (2017 - 2026) Analysis & Trends
Kodiak Sciences has reported Cash from Investing Activities for 10 years, with the latest figure at -$942000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities fell 248.89% year-over-year to -$942000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.2 million (down 37.14% YoY), and the FY2025 full-year result was -$506000.0, up 32.98% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$942000.0, down from -$43000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $173.4 million in Q1 2023, with the low at -$444.0 million in Q2 2022.
- Historically, Cash from Investing Activities has averaged -$5.3 million across 5 years, with a median of -$166000.0 in 2024.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities tumbled 8042.92% — and 2023, when it soared 1048.14%.
- Kodiak Sciences' Cash from Investing Activities stood at $67.0 million in 2022, then sank by 141.49% to -$27.8 million in 2023, then soared by 99.55% to -$124000.0 in 2024, then soared by 65.32% to -$43000.0 in 2025, then sank by 2090.7% to -$942000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$942000.0 (Q1 2026), -$43000.0 (Q4 2025), and -$60000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -2.89 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 638.50 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | -431.90 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 579,519.10 |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | -942,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -942,000.00 |
| Mar 31, 2026 | -942,000.00 |
| Dec 31, 2025 | -43,000.00 |
| Dec 31, 2025 | -43,000.00 |
| Sep 30, 2025 | -60,000.00 |
| Sep 30, 2025 | -60,000.00 |
| Jun 30, 2025 | -133,000.00 |
| Jun 30, 2025 | -133,000.00 |
| Mar 31, 2025 | -270,000.00 |
| Mar 31, 2025 | -270,000.00 |
| Dec 31, 2024 | -124,000.00 |
| Dec 31, 2024 | -124,000.00 |
| Sep 30, 2024 | -205,000.00 |
| Sep 30, 2024 | -205,000.00 |
| Jun 30, 2024 | -260,000.00 |
| Jun 30, 2024 | -260,000.00 |
| Mar 31, 2024 | -166,000.00 |
| Mar 31, 2024 | -166,000.00 |
| Dec 31, 2023 | -27.80 Mn |
| Dec 31, 2023 | -27.80 Mn |